There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

The author describes key considerations for drug manufacturers when evaluating packaging partners.

Tips for Selecting Packaging for Pharmaceutical Drug Manufacturers

Q&A with Robert Hardy, chief executive of Aesica

Q&A with Robert Hardy, Aesica

INTERPHEX 2011 aims to address the industry's unique characteristics.

Innovation, Intelligence, Passion

Alon Vaisman is Applications Development Manager, Pharmaceuticals, at Malvern Instruments Ltd.

Use of in-process particle size analysis has enabled pharmaceutical scientists and process engineers to track the progress of a granulation process and detect its endpoint.

Using Particle Size Analysis To Track The Granulation Process

Ian Haley. Senior Technology & Application Consultant at Mettler Toledo.

In wet granulation, many companies used to rely on empirical data and quality control, but processes and technologies have improved in a variety of ways in recent years.

In-Process Particle Characterisation

Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.

Week of Feb. 21, 2011: Company and People Notes: Gilead to Acquire Calistoga; Bayer Healthcare Appoints Former Pfizer Exec; and More.

Company and People Notes: sanofi to Acquire Genzyme; Lilly Makes Senior Appointments; and More.

Week of Feb. 14, 2011: Company and People Notes: sanofi to Acquire Genzyme; Lilly Makes Senior Appointments; and More.

My drug failed a light-obscuration test, but after I filtered the drug for microscopic particle counting, I couldn?t see any significant particulate on the filter. What might have caused the failure, and why is it not visible?

Invisible Particulate

Paul Kippax is a product manager, Laser Diffraction, Malvern Instruments Ltd., Enigma Business Park, Grovewood Road, Malvern Worcestershire, UK WR14 1XZ, Paul.Kippax@malvern.co.uk.

Deborah Huck is Product Technical Specialist – Morphological Imaging Systems, Malvern Instruments.

Carl Levoguer is Sales Specialist – Analytical Imaging Systems, Malvern Instruments.

Anne Virden is Product Technical Specialist – Diffraction, Malvern Instruments.

Julie Suman is President at NextBreath LLC, USA.

The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.

Characterizing A Nasal Spray Formulation From Droplet To API Particle Size

Pfizer Acquires Ferrosan's Consumer Health Business; Patheon Appoints Former Biogen Exec as CEO; and More.

Week of Feb. 7, 2011: Company and People Notes: Pfizer Acquires Ferrosan's Consumer Health Business; Patheon Appoints Former Biogen Exec as CEO; and More.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes